First Tracks Biotherapeutics Inc
Status: Publicly traded
Direct answer
First Tracks Biotherapeutics Inc is publicly traded on NASDAQ under the ticker TRAX.
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Can you invest in First Tracks Biotherapeutics Inc?
Yes. First Tracks Biotherapeutics Inc trades publicly on NASDAQ as TRAX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for First Tracks Biotherapeutics Inc
Detailed equity research is provided by MarketSnap.